Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B cell modulation in rheumatology.

Gregg J Silverman1, Sahil Khanna

  • 1Rheumatic Diseases Core Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0663, USA. gsilverman@ucsd.edu

Current Opinion in Pharmacology
|July 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of Microbiota Restoration Therapies for Recurrent Clostridioides difficile Infection.

The American journal of gastroenterology·2026
Same author

When Does Clostridioides difficile "Recur"? Reconcile Epidemiologic & Bedside Recurrent CDI definitions.

The Journal of infectious diseases·2026
Same author

Autoantibodies Drive Fcγ Receptor-Dependent Colon Inflammation During Immune Checkpoint Blockade.

bioRxiv : the preprint server for biology·2026
Same author

Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies.

Infectious diseases and therapy·2026
Same author

Clostridioides difficile infection in inflammatory bowel disease: an observational study in flares of ulcerative colitis and a South Asian region-specific systematic review and meta-analysis.

Therapeutic advances in gastroenterology·2026
Same author

AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Inflammatory Bowel Disease: Expert Review.

Gastroenterology·2026
Same journal

Targeting the ischemic cascade: Review on approved and investigational stroke therapies.

Current opinion in pharmacology·2026
Same journal

Senotherapeutic strategies for ovarian aging: Mechanistic insights and translational perspectives.

Current opinion in pharmacology·2026
Same journal

Chrono-immunotherapy in precision oncology: Circadian control of the tumor microenvironment and time-of-day optimization of immune checkpoint blockade.

Current opinion in pharmacology·2026
Same journal

Methotrexate: Integrating molecular pharmacology, systems toxicology, and precision rescue strategies.

Current opinion in pharmacology·2026
Same journal

Acupuncture and non-invasive neuromodulation-induced neuro-endocrine-immune changes associated with the amelioration of depression-like behaviors: A systematic review of animal studies.

Current opinion in pharmacology·2026
Same journal

Alopecia areata: Mechanisms, targeted therapies, and translational challenges.

Current opinion in pharmacology·2026
See all related articles

B cells, implicated in autoimmune diseases through autoantibodies, are now targeted with new agents. These therapies offer novel treatment strategies and insights into B cell roles in immunity.

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • B cell dysregulation is a known factor in autoimmune diseases, primarily through autoantibody production.
  • The broader functional roles of B lymphocytes in autoimmune pathogenesis have been historically underestimated.
  • Recent advancements include the approval of the first B cell-targeting agent for rheumatoid arthritis.

Purpose of the Study:

  • To explore novel therapeutic strategies targeting B cells in autoimmune conditions.
  • To investigate new methods for targeting B cells via surface molecules and survival pathways.
  • To gain new perspectives on the contribution of B cells to immune responses, both normal and pathological.

Main Methods:

  • Development of agents targeting membrane-associated, lineage-specific B cell molecules.

Related Experiment Videos

  • Interference with B-cell-specific pro-survival signaling pathways.
  • Dissection of B cell contributions in physiological and pathological immune responses.

    • Main Results:

    • Emergence of B cell-directed agents as a new mechanistic approach to treatment.
    • Identification of novel strategies for targeting B cells in autoimmune diseases.
    • Enhanced understanding of B cell involvement in immune system function and dysfunction.

    Conclusions:

    • B cell-targeted therapies represent a significant advancement in treating autoimmune diseases like rheumatoid arthritis.
    • Targeting B cells provides a powerful new approach to understanding and managing autoimmune pathogenesis.
    • Further research into B cell functions will likely yield more innovative therapeutic interventions.